ALADAĞ, M. Et Al. 2018. Ten years efficacy of Entecavir and PEG INF combinations therapy on HBsAg loss and seroconversion in patients with chronic HBV. TASL-EASL Educational conference .

ALADAĞ, M., ERDOĞAN, M. A., BİLGİÇ, Y., YILDIRIM, O., ÇAĞIN, Y. F., HARPUTLUOĞLU, M. M. M., ... SEÇKİN, Y.(2018). Ten years efficacy of Entecavir and PEG INF combinations therapy on HBsAg loss and seroconversion in patients with chronic HBV . TASL-EASL Educational conference

ALADAĞ, MURAT Et Al. "Ten years efficacy of Entecavir and PEG INF combinations therapy on HBsAg loss and seroconversion in patients with chronic HBV," TASL-EASL Educational conference, 2018

ALADAĞ, MURAT Et Al. "Ten years efficacy of Entecavir and PEG INF combinations therapy on HBsAg loss and seroconversion in patients with chronic HBV." TASL-EASL Educational conference , 2018

ALADAĞ, M. Et Al. (2018) . "Ten years efficacy of Entecavir and PEG INF combinations therapy on HBsAg loss and seroconversion in patients with chronic HBV." TASL-EASL Educational conference .

@conferencepaper{conferencepaper, author={MURAT ALADAĞ Et Al. }, title={Ten years efficacy of Entecavir and PEG INF combinations therapy on HBsAg loss and seroconversion in patients with chronic HBV}, congress name={TASL-EASL Educational conference}, city={}, country={}, year={2018}}